There are extensive clinical epidemiological data suggesting a strong negative correlation between plasma levels of adiponectin and the occurrence rates of hypertension, left ventricular hypertrophy, and myocardial infarction (26, 30, 31). This evidence concerns the gene ADIPOQ and hypertensive disorder.